| GTO ID | GTC3839 |
| Trial ID | NCT06352281 |
| Disease | Immune Thrombocytopenia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | An Investigator-initiated Trial to Evaluate the Efficacy and Safety of CAR-T Cells Therapy in the Treatment of Chronic or Refractory Primary Immune Thrombocytopenia (ITP) |
| Year | 2024 |
| Country | China |
| Company sponsor | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China |
| Other ID(s) | KM-007 |
| Cohort 1 | |||||||||
|
|||||||||